The endorsed cryoablation system freezes and destroys tumors in patients with early-stage low-risk invasive breast cancer, in conjunction with adjuvant endocrine therapy, according to a Nov. 8 news release from the developer of the system, IceCure Medical.
Advisory panels provide independent expert advice to help the FDA’s decision-making process. Panel endorsements and recommendations are not legally binding, according to the FDA website.
At the Becker's Perioperative Summit, taking place October 29–31 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
